Kiora Pharmaceuticals, Inc. ( KPRX) - Key Metrics
KPRX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.34 | -$0.31 | -$0.31 |
| 2026Q1 | $0 | -$0.58 | -$0.76 | -$0.76 |
| 2025Q4 | $0 | -$1.56 | -$0.52 | -$0.54 |
| 2025Q3 | $0 | $0.01 | -$0.30 | -$0.30 |
| 2025Q2 | $0 | -$0.54 | -$0.95 | -$0.96 |
KPRX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.93 |
| 2026Q1 | 0% | -0.83 |
| 2025Q4 | 0% | -0.32 |
| 2025Q3 | 0% | 112.10 |
| 2025Q2 | 0% | -1.33 |
KPRX
Price: $2.59
52 week price:
Earnings Per Share: -2.46 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 47600
Market Capitalization: 11.7 million